Rare RNA Polymerase II failure modes mark the cancer-driving genes most affected by epigenetic perturbation
The paper introduces compPASS, a tool to identify Pol2 failure modes in cancer, revealing rare modes linked to gene regulation and therapy response.
bioRxiv · May 31, 2026 · PreprintBioinformatics